157 related articles for article (PubMed ID: 22548802)
1. Detection of Transglutaminase 2 conformational changes in living cell.
Pavlyukov MS; Antipova NV; Balashova MV; Shakhparonov MI
Biochem Biophys Res Commun; 2012 May; 421(4):773-9. PubMed ID: 22548802
[TBL] [Abstract][Full Text] [Related]
2. Using FLIM-FRET to measure conformational changes of transglutaminase type 2 in live cells.
Caron NS; Munsie LN; Keillor JW; Truant R
PLoS One; 2012; 7(8):e44159. PubMed ID: 22952912
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.
Jang GY; Jeon JH; Cho SY; Shin DM; Kim CW; Jeong EM; Bae HC; Kim TW; Lee SH; Choi Y; Lee DS; Park SC; Kim IG
Oncogene; 2010 Jan; 29(3):356-67. PubMed ID: 19838207
[TBL] [Abstract][Full Text] [Related]
4. Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implications.
Grosso H; Mouradian MM
Pharmacol Ther; 2012 Mar; 133(3):392-410. PubMed ID: 22212614
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis.
Tatsukawa H; Kojima S
Cell Biol Int; 2010 Feb; 34(3):325-34. PubMed ID: 20192918
[TBL] [Abstract][Full Text] [Related]
6. Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses.
Stephens P; Grenard P; Aeschlimann P; Langley M; Blain E; Errington R; Kipling D; Thomas D; Aeschlimann D
J Cell Sci; 2004 Jul; 117(Pt 15):3389-403. PubMed ID: 15199098
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of allosteric regulation of transglutaminase 2 by GTP.
Begg GE; Carrington L; Stokes PH; Matthews JM; Wouters MA; Husain A; Lorand L; Iismaa SE; Graham RM
Proc Natl Acad Sci U S A; 2006 Dec; 103(52):19683-8. PubMed ID: 17179049
[TBL] [Abstract][Full Text] [Related]
8. The 55 kDa tissue transglutaminase cross-linking active isoform TG induces cell death.
Fraij BM
Mol Carcinog; 2015 Sep; 54(9):720-9. PubMed ID: 24464646
[TBL] [Abstract][Full Text] [Related]
9. Transglutaminase 2 in the balance of cell death and survival.
Fésüs L; Szondy Z
FEBS Lett; 2005 Jun; 579(15):3297-302. PubMed ID: 15943974
[TBL] [Abstract][Full Text] [Related]
10. Isopeptidase activity of human transglutaminase 2: disconnection from transamidation and characterization by kinetic parameters.
Király R; Thangaraju K; Nagy Z; Collighan R; Nemes Z; Griffin M; Fésüs L
Amino Acids; 2016 Jan; 48(1):31-40. PubMed ID: 26250429
[TBL] [Abstract][Full Text] [Related]
11. Transglutaminase 2: a multi-functional protein in multiple subcellular compartments.
Park D; Choi SS; Ha KS
Amino Acids; 2010 Aug; 39(3):619-31. PubMed ID: 20148342
[TBL] [Abstract][Full Text] [Related]
12. Acyl transfer mechanisms of tissue transglutaminase.
Keillor JW; Clouthier CM; Apperley KYP; Akbar A; Mulani A
Bioorg Chem; 2014 Dec; 57():186-197. PubMed ID: 25035302
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of transglutaminase 2 under different oxidative stress conditions.
Caccamo D; Currò M; Ferlazzo N; Condello S; Ientile R
Amino Acids; 2012 Feb; 42(2-3):1037-43. PubMed ID: 21805137
[TBL] [Abstract][Full Text] [Related]
14. Substrate preference of transglutaminase 2 revealed by logistic regression analysis and intrinsic disorder examination.
Csosz E; Bagossi P; Nagy Z; Dosztanyi Z; Simon I; Fesus L
J Mol Biol; 2008 Nov; 383(2):390-402. PubMed ID: 18761350
[TBL] [Abstract][Full Text] [Related]
15. Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement.
Strnad P; Harada M; Siegel M; Terkeltaub RA; Graham RM; Khosla C; Omary MB
Gastroenterology; 2007 Apr; 132(4):1515-26. PubMed ID: 17408647
[TBL] [Abstract][Full Text] [Related]
16. Functional significance of five noncanonical Ca2+-binding sites of human transglutaminase 2 characterized by site-directed mutagenesis.
Király R; Csosz E; Kurtán T; Antus S; Szigeti K; Simon-Vecsei Z; Korponay-Szabó IR; Keresztessy Z; Fésüs L
FEBS J; 2009 Dec; 276(23):7083-96. PubMed ID: 19878304
[TBL] [Abstract][Full Text] [Related]
17. Regulation of ATPase activity of transglutaminase 2 by MT1-MMP: implications for mineralization of MC3T3-E1 osteoblast cultures.
Nakano Y; Forsprecher J; Kaartinen MT
J Cell Physiol; 2010 Apr; 223(1):260-9. PubMed ID: 20049897
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of tissue transglutaminase.
Keillor JW; Apperley KY; Akbar A
Trends Pharmacol Sci; 2015 Jan; 36(1):32-40. PubMed ID: 25500711
[TBL] [Abstract][Full Text] [Related]
19. Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation.
Colak G; Keillor JW; Johnson GV
PLoS One; 2011 Jan; 6(1):e16665. PubMed ID: 21304968
[TBL] [Abstract][Full Text] [Related]
20. Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity.
Begg GE; Holman SR; Stokes PH; Matthews JM; Graham RM; Iismaa SE
J Biol Chem; 2006 May; 281(18):12603-9. PubMed ID: 16522628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
